Home » Topics » Regulatory » Patents

Patents
RSS

Jeil Pharmaceutical synthesizes novel H(+)/K(+) ATPase inhibitors

Jan. 23, 2018

Myeloperoxidase/eosinophil peroxidase inhibitors patented by Bristol-Myers Squibb

Jan. 23, 2018

Venenum Biodesign discovers G-protein coupled bile acid receptor 1 agonists

Jan. 23, 2018

St Jude Children's Research Hospital patents new anti-CD7 chimeric antigen receptors

Jan. 22, 2018

Roche identifies novel anti-influenza compounds

Jan. 22, 2018

HDAC/histone-lysine N-methyltransferase EHMT2 inhibitors discovered at Georgia State University

Jan. 22, 2018

The University of Kentucky patents prostaglandin E synthase inhibitors

Jan. 22, 2018

Merck & Co. and Idenix describe novel HCV RNA polymerase NS5B inhibitors

Jan. 22, 2018

Novel mutant IDH1 inhibitors presented by HHS

Jan. 19, 2018

Zhejiang Hisun Pharmaceutical presents new SERAMs for cancer

Jan. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...